BIOMAT Database Logo BIOMAT Database Logo

Synthesis, characterization and biological evaluation of novel 2,5 substituted-1,3,4 oxadiazole derivatives. 2017

Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Department of Chemistry, Government College of Engineering, Salem 11, Tamil Nadu, India.

In the present study, a series of 3-(5-cyclohexyl-1,3,4-oxadiazol-2-yl)-N-substituted aniline have been synthesized by multistep reaction scheme. Benzohydrazide was used as the starting material. The structures of all synthesized compounds are characterized and confirmed by FT-IR, 1H and C13 NMR and mass spectral studies with the intention of developing the novel biologically active compounds. All title synthetic compounds were screened for their antidiabetic, anti-inflammatory and anticancer activities.

UI MeSH Term Description Entries

Related Publications

Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Synthesis and fungicidal activity of novel 2,5-disubstituted-1,3,4-oxadiazole derivatives.
November 2012, Journal of agricultural and food chemistry,
Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Novel 2,5-disubstituted-1,3,4-oxadiazole derivatives as MAO-B inhibitors: Synthesis, biological evaluation and molecular modeling studies.
July 2021, Bioorganic chemistry,
Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Synthesis and antimicrobial evaluation of some 2,5 disubstituted 1,3,4-oxadiazole derivatives.
August 2017, Research in pharmaceutical sciences,
Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Synthesis and biological evaluation of some 1,3,4-oxadiazole derivatives.
November 2010, European journal of medicinal chemistry,
Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Design, synthesis and biological evaluation of 1,3,4-oxadiazole derivatives.
November 2010, European journal of medicinal chemistry,
Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Neuroprotective evaluation of novel substituted 1,3,4-oxadiazole and aroylhydrazone derivatives.
March 2022, Bioorganic & medicinal chemistry letters,
Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Synthesis, characterization, and in vitro anticancer evaluation of novel 2,5-disubstituted 1,3,4-oxadiazole analogue.
January 2014, BioMed research international,
Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Synthesis of novel 1,3,4-oxadiazole derivatives and their biological properties.
June 2009, Acta pharmaceutica (Zagreb, Croatia),
Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Synthesis and biological evaluation of novel 4β-(1,3,4-oxadiazole-2-amino)-podophyllotoxin derivatives.
July 2012, Bioorganic & medicinal chemistry letters,
Selvaraj Kavitha, and Kulanthai Kannan, and Sadhasivam Gnanavel
Synthesis and biological evaluation of 2,5-disubstituted 1,3,4-oxadiazole derivatives with both COX and LOX inhibitory activity.
December 2011, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!